Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Endocrine 1Breast 1

Conditions

Polycystic Ovary Syndrome 1Pituitary Neoplasms 1Osteoporosis 1Infertility, Female 1Fractures, Bone 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Hormone Replacement Therapy × Clear all
NCT06679816 2025-01-14

Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors

Beijing Tiantan Hospital

Phase 4 Recruiting
882 enrolled
Endocrine

Pituitary Neoplasms

NCT05189873 2022-01-13

GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes

Tehran University of Medical Sciences

Phase 3 Completed
128 enrolled

Infertility, Female, Polycystic Ovary Syndrome

NCT00252408 2009-09-04

Danish Osteoporosis Prevention Study

University of Aarhus

Phase 4 Completed
2,000 enrolled
Breast

Breast Neoplasms, Osteoporosis, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡